A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

This study will evaluate 0.15% brimonidine tartrate in patients with primary open angle glaucoma and ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma, Open-Angle Eye Diseases Glaucoma Ocular Hypertension

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Shanghai, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of open-angle glaucoma or ocular hypertension

Exclusion criteria

Used Alphagan® in previous 3 months

Treatment and study plan

0.15% Brimonidine Tartrate

Drug

0.15% Brimonidine Tartrate (Alphagan® P) 1 drop in the affected eye 3 times daily for 3 months.

Other names: Alphagan® P

Primary outcomes

Change From Baseline in Intraocular Pressure (IOP) in the Study Eye

Time frame: Baseline, Month 3

IOP is a measurement of the fluid pressure inside the eye. A negative number change from baseline indicates a reduction in IOP (improvement), and a positive number change from baseline indicates an increase (worsening).

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Acronym: APOTUS

Important dates

Study start: 2010
Primary completion: 2013
Study completion: 2013
First posted: Dec 6, 2013
Registry last updated: Jul 22, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed